Navigation Links
Synthetic Biology Scorecard finds federal agencies responding to bioethics report
Date:7/16/2012

WASHINGTON Federal agencies have started taking steps to address the recommendations in a 2010 report from the presidential bioethics commission to improve the governance of synthetic biology research and development, though the government has not fully addressed any of the report recommendations, according to a scorecard tracking the efforts.

The Synthetic Biology Project at the Woodrow Wilson International Center for Scholars launched the web-based Synthetic Biology Scorecard in February to track federal and non-federal efforts to implement the recommendations in New Directions: The Ethics of Synthetic Biology and Emerging Technologies, a December 2010 report from the Presidential Commission for the Study of Bioethical Issues. The recommendations seek to minimize risks from the technology while ensuring that social and economic benefits are realized.

Eighteen months after the release of the report, information collected by the Project and submitted by users finds that steps have been taken by the U.S. government over the past four months to continue addressing the report recommendations. These measures include a new White House-led interagency working group looking at government work on the issue; a recent six-party meeting at the National Academy of Sciences (the last in a series of three meetings between the United States, United Kingdom and China); and the development and release of the National Bioeconomy Blueprint.

Still, the Scorecard finds that none of the recommendations have been fully addressed, including six recommendations that called for federal action within 18 months, or by mid-June 2012. Of the six recommendations calling for action within 18 months, five of the recommendations saw some level of government activity.

Of the 17 recommendations tracked by the Scorecard, 13 had some level of federal activity and four had no activity, including a recommendation calling for risk assessments before research organisms or commercial products involving the technology are released into the environment and a recommendation calling for the identification of reliable containment and control mechanisms.

President Obama requested the Commission's report more than two years ago in response to important advancements in the field of synthetic biology. On May 20, 2010, scientists at the J.C. Venter Institute unveiled a bacterial cell controlled by a synthetic genome. The same day, the president asked the Commission to study "the implications of this scientific milestone . . . [and] consider the potential medical, environmental, security, and other benefits of this field of research, as well as any potential health, security, or other risks."

The Scorecard has new features to improve usability. People are encouraged to submit work by agencies, organizations, states and others that fulfill the Commission recommendations. The Project plans to continue to highlight the progress towards implementing the recommendations.


'/>"/>

Contact: Aaron Lovell
aaron.lovell@wilsoncenter.org
202-691-4320
Woodrow Wilson International Center for Scholars/Science and Technology Innovation Program
Source:Eurekalert

Related biology news :

1. Synthetic diamond steps closer to next generation of high performance electrochemical applications
2. UC Santa Barbara researchers develop synthetic platelets
3. New synthetic biology technique boosts microbial production of diesel fuel
4. BWH launches a new research division focused on integrating systems biology and medicine
5. American Society for Microbiologys newest journal earns a high impact factor in latest rankings
6. Cell biology -- new insights into the life of microtubules
7. 3-V Biosciences Appoints Douglas I. Buckley, PhD, as Vice President of Biology
8. Oligonucleotide Delivery: Biology, Engineering and Development Conference
9. GW announces creation of Computational Biology Institute to conduct integrated research
10. MARC travel award announced for the 2012 GSA Yeast Genetics and Molecular Biology Meeting
11. Infection biology: The elusive third factor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2016)... 2016 This BCC Research report provides ... reviewing the recent advances in high throughput ‘omic ... field forward. Includes forecast through 2019. ... and opportunities that exist in the bioinformatic market. ... as well as IT and bioinformatics service providers. ...
(Date:2/2/2016)... 2016   Parabon NanoLabs (Parabon) announced ... Research Office and the Defense Forensics and Biometrics ... the company,s Snapshot Kinship Inference software ... generally, defense-related DNA forensics.  Although Snapshot is best ... and ancestry from DNA evidence), it also has ...
(Date:2/1/2016)... 2016  Today, the first day of American Heart ... develop a first of its kind workplace health solution ... In the first application of Watson ... ), and Welltok will create a new offering that ... analytics, delivered on Welltok,s health optimization platform. The effort ...
Breaking Biology News(10 mins):
(Date:2/3/2016)...  Discovery Laboratories, Inc. (NASDAQ: DSCO ), ... surfactant therapies for respiratory diseases, today announced that ... award as a component of employment compensation for ... and Chief Executive Officer.  The award was approved ... 2016 and granted as an inducement material to ...
(Date:2/3/2016)... , Feb. 3, 2016 Ascendis Pharma A/S ... that applies its innovative TransCon technology to address significant ... an upcoming investor conference.Event:2016 Leerink Partners Global Healthcare Conference ... , Wednesday, February 10, 2016 Time:  , 11:55am ... . --> An audio webcast of this ...
(Date:2/3/2016)... N.J. , Feb. 3, 2016 ... totaling more than $1 million for researchers in ... working on health-related research that demonstrates exciting potential. ... round of funding for the New Jersey Health Foundation ... faculty members at these educational institutions— Princeton University, ...
(Date:2/3/2016)... ... 03, 2016 , ... ProMIS Neurosciences is currently in the ... misfolded, propagating strains of Amyloid beta involved in Alzheimer’s disease. The Company plans ... Following on from the first misfolded Amyloid beta target announced on Nov. 12, ...
Breaking Biology Technology: